These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16102030)

  • 21. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
    Jakubowski H
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():155-67. PubMed ID: 19261978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of hyperhomocysteinemia in nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF)-mediated vasodilatation.
    Heil SG; De Vriese AS; Kluijtmans LA; Mortier S; Den Heijer M; Blom HJ
    Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):911-6. PubMed ID: 15704255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia.
    He L; Zeng H; Li F; Feng J; Liu S; Liu J; Yu J; Mao J; Hong T; Chen AF; Wang X; Wang G
    Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E1061-5. PubMed ID: 20858749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.
    Böger RH; Bode-Böger SM; Sydow K; Heistad DD; Lentz SR
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1557-64. PubMed ID: 10845872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homocysteine impaired endothelial function through compromised vascular endothelial growth factor/Akt/endothelial nitric oxide synthase signalling.
    Yan TT; Li Q; Zhang XH; Wu WK; Sun J; Li L; Zhang Q; Tan HM
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1071-7. PubMed ID: 20698860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death, and contributes to the cevelopment of atherosclerosis in hyperhomocysteinemia.
    Hossain GS; van Thienen JV; Werstuck GH; Zhou J; Sood SK; Dickhout JG; de Koning AB; Tang D; Wu D; Falk E; Poddar R; Jacobsen DW; Zhang K; Kaufman RJ; Austin RC
    J Biol Chem; 2003 Aug; 278(32):30317-27. PubMed ID: 12738777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
    Stühlinger MC; Stanger O
    Curr Drug Metab; 2005 Feb; 6(1):3-14. PubMed ID: 15720202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Hyperhomocysteinemia and Hyperuricemia in Pathogenesis of Atherosclerosis.
    Zhao J; Chen H; Liu N; Chen J; Gu Y; Chen J; Yang K
    J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2695-2699. PubMed ID: 28986198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homocysteine induces oxidative stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin.
    Topal G; Brunet A; Millanvoye E; Boucher JL; Rendu F; Devynck MA; David-Dufilho M
    Free Radic Biol Med; 2004 Jun; 36(12):1532-41. PubMed ID: 15182855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homocysteine stimulates NADPH oxidase-mediated superoxide production leading to endothelial dysfunction in rats.
    Edirimanne VE; Woo CW; Siow YL; Pierce GN; Xie JY; O K
    Can J Physiol Pharmacol; 2007 Dec; 85(12):1236-47. PubMed ID: 18066125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular oxidant stress and inflammation in hyperhomocysteinemia.
    Papatheodorou L; Weiss N
    Antioxid Redox Signal; 2007 Nov; 9(11):1941-58. PubMed ID: 17822365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetrahydrobiopterin attenuates homocysteine induced endothelial dysfunction.
    Dhillon B; Badiwala MV; Maitland A; Rao V; Li SH; Verma S
    Mol Cell Biochem; 2003 May; 247(1-2):223-7. PubMed ID: 12841652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperhomocysteinemia and its role in the development of atherosclerosis.
    Lawrence de Koning AB; Werstuck GH; Zhou J; Austin RC
    Clin Biochem; 2003 Sep; 36(6):431-41. PubMed ID: 12951169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homocysteine to hydrogen sulfide or hypertension.
    Sen U; Mishra PK; Tyagi N; Tyagi SC
    Cell Biochem Biophys; 2010 Jul; 57(2-3):49-58. PubMed ID: 20387006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of oxidative stress by homocyst(e)ine impairs endothelial function.
    Mujumdar VS; Aru GM; Tyagi SC
    J Cell Biochem; 2001; 82(3):491-500. PubMed ID: 11500925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia.
    Doshi S; McDowell I; Goodfellow J; Stabler S; Boger R; Allen R; Newcombe R; Lewis M; Moat S
    Metabolism; 2005 Mar; 54(3):351-60. PubMed ID: 15736113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Homocysteine, endothelial dysfunction and cardiovascular risk: pathomechanisms and therapeutic options].
    Sydow K; Böger RH
    Z Kardiol; 2001 Jan; 90(1):1-11. PubMed ID: 11220081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of methionine-induced hyperhomocysteinemia on endothelium-dependent vasodilation and oxidative status in healthy adults.
    Chao CL; Kuo TL; Lee YT
    Circulation; 2000 Feb; 101(5):485-90. PubMed ID: 10662744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitric oxide bioavailability dysfunction involves in atherosclerosis.
    Chen JY; Ye ZX; Wang XF; Chang J; Yang MW; Zhong HH; Hong FF; Yang SL
    Biomed Pharmacother; 2018 Jan; 97():423-428. PubMed ID: 29091892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice.
    Weiss N; Heydrick S; Zhang YY; Bierl C; Cap A; Loscalzo J
    Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):34-41. PubMed ID: 11788458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.